First Time Loading...

Chemomab Therapeutics Ltd
NASDAQ:CMMB

Watchlist Manager
Chemomab Therapeutics Ltd Logo
Chemomab Therapeutics Ltd
NASDAQ:CMMB
Watchlist
Price: 1.0699 USD 0.93% Market Closed
Updated: Jun 1, 2024

Chemomab Therapeutics Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chemomab Therapeutics Ltd
Depreciation & Amortization Peer Comparison

Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Chemomab Therapeutics Ltd
NASDAQ:CMMB
Depreciation & Amortization
$67k
CAGR 3-Years
50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Depreciation & Amortization
$1.1m
CAGR 3-Years
19%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Depreciation & Amortization
$12.7m
CAGR 3-Years
38%
CAGR 5-Years
27%
CAGR 10-Years
16%
Urogen Pharma Ltd
NASDAQ:URGN
Depreciation & Amortization
$705k
CAGR 3-Years
10%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Depreciation & Amortization
$56k
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Depreciation & Amortization
₪2.8m
CAGR 3-Years
37%
CAGR 5-Years
70%
CAGR 10-Years
29%

See Also

What is Chemomab Therapeutics Ltd's Depreciation & Amortization?
Depreciation & Amortization
67k USD

Based on the financial report for Dec 31, 2023, Chemomab Therapeutics Ltd's Depreciation & Amortization amounts to 67k USD.

What is Chemomab Therapeutics Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
50%

Over the last year, the Depreciation & Amortization growth was 12%. The average annual Depreciation & Amortization growth rates for Chemomab Therapeutics Ltd have been 50% over the past three years .